As shown in Figure 7C , treatment of cells with the A 2A R agonist CGS21680 significantly reduced IL-8 release triggered by M5 stimulation, whereas cells treated with BAY606583 showed a trend toward reduced IL-8 levels.
← all excerpts
Oncostatin M upregulates CD73 via the MAPK pathway in keratinocytes to promote an adenosine-dependent anti-inflammatory response in psoriasis.
2
—
—
The sentences
Treatment of cells with the A 2B R agonist BAY606583 (1 μM) also reduced IL-8 levels in M5-stimulated cells, although the effect did not reach statistical significance ( Figure 6B ).